Monday, it was Genta (nasdaq: GNTA - news - people ) being punished.

FORBES: Magazine Article

Aventis will pay for Genta's (nasdaq: GNTA - news - people ) U.S. sales force, and the two companies will split U.S. sales of Genasense evenly.

FORBES: Magazine Article

When Genta (nasdaq: GNTA - news - people ) signed a large deal with Aventis (nyse: AVE - news - people ), its shares continued to fall.

FORBES: Genentech Loses To Hungry Academics

Genasense, a melanoma drug, was rejected by a panel in 2004 after its maker, Genta (nasdaq: GNTA - news - people ), argued that although the drug failed to improve survival, it shrank tumors.

FORBES: Dendreon Decision Could Mean FDA Shift

Before the ASH meeting began, Raymond Warrell , chief executive of Genta (nasdaq: GNTA - news - people ), commented that he thinks Velcade is one of the rare cases where fast-tracking a drug makes sense.

FORBES: Magazine Article

The next closest antisense drug to being approved for sale is Genasense, a cancer drug invented by Genta (nasdaq: GNTA - news - people ) that is being co-developed with Aventis (nyse: AVE - news - people ) as part of a deal signed a year ago.

FORBES: Antisense Still Makes Sense